[HTML] cell.comFull View

[HTML][HTML] Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancer

SL Freshour, THP Chen, B Fisk, H Shen, M Mosior… - Iscience, 2023 - cell.com
To explore mechanisms of response to combined PD-1/CTLA-4 immune checkpoint
blockade (ICB) treatment in individual cell types, we generated scRNA-seq using a mouse …
被引用次数：2 相关文章
[HTML] nih.gov

[HTML][HTML] Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancer

SL Freshour, THP Chen, B Fisk, H Shen, M Mosior… - iScience, 2023 - ncbi.nlm.nih.gov
To explore mechanisms of response to combined PD-1/CTLA-4 immune checkpoint
blockade (ICB) treatment in individual cell types, we generated scRNA-seq using a mouse …

Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancer

SL Freshour, THP Chen, B Fisk, H Shen, M Mosior… - bioRxiv, 2023 - biorxiv.org
To explore mechanisms of response to combined PD-1/CTLA-4 immune checkpoint
blockade (ICB) treatment in individual cell types, we generated scRNA-seq using a mouse …

Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancer

SL Freshour, THP Chen, B Fisk, H Shen, M Mosior… - 2023 - digitalcommons.wustl.edu
To explore mechanisms of response to combined PD-1/CTLA-4 immune checkpoint
blockade (ICB) treatment in individual cell types, we generated scRNA-seq using a mouse …

Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancer

S Freshour, T Chen, B Fisk, H Shen, M Mosior… - Iscience, 2023 - europepmc.org
To explore mechanisms of response to combined PD-1/CTLA-4 immune checkpoint
blockade (ICB) treatment in individual cell types, we generated scRNA-seq using a mouse …

Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancer

SL Freshour, THP Chen, B Fisk, H Shen… - …, 2023 - pubmed.ncbi.nlm.nih.gov
To explore mechanisms of response to combined PD-1/CTLA-4 immune checkpoint
blockade (ICB) treatment in individual cell types, we generated scRNA-seq using a mouse …
[HTML] cell.com

[HTML][HTML] Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancer

SL Freshour, THP Chen, B Fisk, H Shen, M Mosior… - iScience, 2023 - cell.com
To explore mechanisms of response to combined PD-1/CTLA-4 immune checkpoint
blockade (ICB) treatment in individual cell types, we generated scRNA-seq using a mouse …

[引用][C] Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancer

SL Freshour, THP Chen, B Fisk, H Shen, M Mosior… - …, 2023 - ui.adsabs.harvard.edu
Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB
treatment in a mouse model of bladder cancer - NASA/ADS Now on home page ads icon ads …
[HTML] sciencedirect.com

[HTML][HTML] Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancer

SL Freshour, THP Chen, B Fisk, H Shen, M Mosior… - iScience, 2023 - Elsevier
To explore mechanisms of response to combined PD-1/CTLA-4 immune checkpoint
blockade (ICB) treatment in individual cell types, we generated scRNA-seq using a mouse …

Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancer.

SL Freshour, TH Chen, B Fisk, H Shen, M Mosior… - Iscience, 2023 - europepmc.org
To explore mechanisms of response to combined PD-1/CTLA-4 immune checkpoint
blockade (ICB) treatment in individual cell types, we generated scRNA-seq using a mouse …